Skip to Main Content

Paper Details

Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data.
Cancer Epidemiol Biomarkers Prev
1
2022
EGFR, EGFR Mutations, ILCCO, Lung Cancer, NSCLC, Non-Small Cell Lung Cancers, non-small cell lung cancers, patients
Author NameAffiliation
Jolanta LissowskaM. Sklodowska-Curie National Research Institute of Oncology
Jolanta LissowskaM. Sklodowska-Curie National Research Institute of Oncology
Neil E CaporasoNational Cancer Institute, National Institutes of Health
Neil E CaporasoNational Cancer Institute, National Institutes of Health
John K FieldThe University of Liverpool, Department of Molecular and Clinical Cancer Medicine
Loic Le MarchandUniversity of Hawaii Cancer Center
Maria Teresa LandiNational Cancer Institute, National Institutes of Health
Ping YangMayo Clinic
Rui Manuel ReisMolecular Oncology Research Center, Barretos Cancer Hospital
Rui Manuel Reis
Rui Manuel ReisLife and Health Sciences Research Institute (ICVS), University of Minho
Rayjean J HungDalla Lana School of Public Health, University of Toronto
Rayjean J HungLunenfeld-Tanenbaum Research Institute
Wei XuThe Princess Margaret Cancer Centre and University Health Network, University of Toronto
Wei XuDalla Lana School of Public Health, University of Toronto
Geoffrey LiuThe Princess Margaret Cancer Centre and University Health Network, University of Toronto
Geoffrey LiuDalla Lana School of Public Health, University of Toronto
  • 1 - 17

Datasets